— Know what they know.
Not Investment Advice

PXYN OTC

Praxsyn Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.8% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 55 · $6347 mcap · 521M float · 0.103% daily turnover

Cash Flow Trends

Operating Cash Flow
-$24M -1269.3% ▼
Capital Expenditures
$68K -1592.6% ▼
Free Cash Flow
-$24M -1270.0% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$506K +0.0% ▲
Net Change in Cash
$1M +511.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2010FY2011FY2012FY2013FY2014
— Operating Activities —
Net Income-$4M-$8M-$1M$230K-$12M
Depreciation & Amort.$26K$63K$52K$9K$16K
Stock-Based Comp.$376K$40K$169K$0$2K
Change in Working Capital$581K$1M$651K-$4M-$60M
Other Non-Cash Items$991K$4M$62K$1M$49M
Operating Cash Flow-$2M-$2M-$284K-$2M-$24M
— Investing Activities —
Capital Expenditures-$98K-$88K$0-$4K-$68K
Acquisitions (Net)$0$0$0$0$485K
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$98K-$88K$0-$4K$417K
— Financing Activities —
Net Debt Issuance$1M$0$102K$89K-$566K
Stock Repurchased$0$0$0$0-$506K
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$1M$26M
Financing Cash Flow$4M$556K$328K$1M$24M
Net Change in Cash$1M-$1M$43K-$288K$1M
Cash End of Period$2M$38K$82K$37K$1M
Free Cash Flow-$2M-$2M-$284K-$2M-$24M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms